INTRODUCTION {#s1}
============

Tracheal cancer is a rare disease with relatively poor outcomes \[[@R1], [@R2]\]. This cancer accounts for less than 0.1% of all malignancies, and the 5-year overall survival (OS) rate is only 27.1% \[[@R2], [@R3]\]. Because most previous studies on tracheal cancer were based on small samples \[[@R4]--[@R7]\], large sample studies are needed to improve our understanding of this complex disease. In addition, the concepts of health and disease have evolved greatly over the past decades, with a greater emphasis now placed on the role of social determinants in disease development \[[@R8], [@R9]\]. However, former prognosis analysis mainly focused on pathological and clinical characteristics \[[@R10]\], with few studies addressing the impact of social determinants.

Marital status is an independent prognostic factor for survival in numerous cancers, and married patients have demonstrated better survival in lung cancer, prostate cancer, and breast cancer \[[@R11]--[@R13]\]. Marital status is an important type of social support and can greatly affect the patient\'s mood, quality of life, financial status, and coping strategies \[[@R14], [@R15]\]. However, our knowledge about its effect on prognosis in tracheal cancer is limited.

In this study, we used data from the Surveillance, Epidemiology, and End Results (SEER) program, which consists of 18 population-based cancer registries covering approximately 30% of the population in the United States. This database provides both clinical records and data on social determinants, including marital status and county level socio-economic data. In this study, we used SEER data to examine the effect of marital status and other prognostic factors on tracheal cancer.

RESULTS {#s2}
=======

Demographic and clinical characteristics {#s2_1}
----------------------------------------

A total of 600 patients in the SEER database from 1990 to 2010 were included in this study. Demographic, clinicopathologic, and treatment data are shown in Table [1](#T1){ref-type="table"}. Among the included patients, 344 were married (57.33%), and 256 were unmarried (42.67%), with mean ages of 63.65 ± 12.98 and 63.60 ± 12.98 years, respectively (*p* = 0.963). Compared with unmarried patients, married patients were more likely to be male (62.79% vs. 45.31%, *p* \< 0.001). Despite that the race ratio was different between the married and the unmarried group (*p* = 0.005), the proportion of white patients was highest in both groups (79.65% vs. 78.13%). The two groups did not differ significantly with regards to other baseline characteristics, including histologic type, disease extension, tumor grade, selection of surgery, and selection of radiotherapy (*p* \> 0.05).

###### Baseline demographic and clinical characteristics of patients

                                                                       Total           Married         Unmarried[^b^](#tfn_002){ref-type="table-fn"}   *P* value[^c^](#tfn_003){ref-type="table-fn"}
  -------------------------------------------------------------------- --------------- --------------- ----------------------------------------------- -----------------------------------------------
  **Sex**                                                                                                                                              \< 0.001
   Male                                                                332 (55.33)     216 (62.79)     116 (45.31)                                     
   Female                                                              268 (44.67)     128 (37.21)     140 (54.69)                                     
  **Age at diagnosis, y ± SD**                                         63.63 ± 14.53   63.65 ± 12.98   63.60 ± 12.98                                   0.963
   Race                                                                                                                                                0.005
   White                                                               474 (79.00)     274 (79.65)     200 (78.13)                                     
   Black                                                               77 (12.83)      34 (9.88)       43 (16.80)                                      
   Other                                                               49 (8.17)       36 (10.47)      14 (5.08)                                       
  **Disease Extension**                                                                                                                                0.211
   Localized                                                           220 (36.67)     134 (38.95)     86 (33.59)                                      
   Regional                                                            205 (34.17)     110 (31.98)     95 (37.11)                                      
   Distant                                                             96 (16.00)      50 (14.53)      46 (17.97)                                      
   Unknown                                                             79 (13.17)      50 (14.53)      29 (11.33)                                      
  **Grade**                                                                                                                                            0.368
   Grade I (well differentiated)                                       29 (4.83)       14 (4.07)       15 (5.86)                                       
   Grade II (moderately differentiated)                                144 (24.00)     78 (22.67)      66 (25.78)                                      
   Grade III(poorly differentiated)                                    141 (23.50)     82 (23.84)      59 (23.05)                                      
   Grade IV(undifferentiated)                                          26 (4.33)       19 (5.52)       7 (2.73)                                        
   Unknown                                                             260 (43.33)     151 (43.90)     109 (42.58)                                     
  **Histology**                                                                                                                                        0.609
   Squamous cell carcinoma                                             299 (49.83)     171 (49.71)     128 (50.00)                                     
   Adenoid cystic carcinoma                                            107 (17.83)     64 (18.60)      43 (16.80)                                      
   Small cell carcinoma                                                51 (8.50)       25 (7.27)       26 (10.16)                                      
   Others                                                              143 (23.83)     84 (24.42)      59 (23.05)                                      
  **Low-Grade Malignant Tumors[^d^](#tfn_004){ref-type="table-fn"}**                                                                                   0.729
   Yes                                                                 133 (22.17)     78 (22.67)      55 (21.48)                                      
   No                                                                  467 (77.83)     266 (77.33)     201 (78.52)                                     
  **Surgery**                                                                                                                                          0.744
   Total resection                                                     39 (6.50)       25 (7.27)       14 (5.47)                                       
   Subtotal resection                                                  230 (38.33)     134 (38.95)     96 (37.50)                                      
   No cancer directed surgery                                          323 (53.83)     180 (52.33)     143 (55.86)                                     
   Unknown                                                             8 (1.33)        5 (1.45)        3 (1.17)                                        
  **Radiotherapy**                                                                                                                                     0.657
   Radiotherapy                                                        378 (63.00)     222 (64.53)     156 (60.94)                                     
   No radiotherapy                                                     199 (33.17)     109 (31.69)     90 (35.16)                                      
   Unknown                                                             23 (3.83)       13 (3.78)       10 (3.91)                                       
  **High School Education Rate[^e^](#tfn_005){ref-type="table-fn"}**                                                                                   0.806
   Lower 50%                                                           327 (54.50)     186 (54.07)     141 (55.08)                                     
   Upper 50%                                                           273 (45.50)     158 (45.93)     115 (44.92)                                     
  **Median Household Income[^e^](#tfn_005){ref-type="table-fn"}**                                                                                      0.339
   Lower 50%                                                           134 (22.33)     72 (20.93)      62 (24.22)                                      
   Upper 50%                                                           466 (77.77)     272 (79.07)     194 (75.78)                                     
  **Unemployed[^e^](#tfn_005){ref-type="table-fn"}**                                                                                                   0.890
   Lower 50%                                                           309 (51.50)     178 (51.74)     131 (51.17)                                     
   Upper 50%                                                           291 (48.50)     166 (48.26)     125 (48.83)                                     
  **White Collar[^e^](#tfn_005){ref-type="table-fn"}**                                                                                                 0.787
   Lower 50%                                                           184 (30.67)     107 (31.10)     77 (30.08)                                      
   Upper 50%                                                           416 (69.27)     237 (68.90)     179 (69.92)                                     

Data were presented as number (percentage) of patients.

Unmarried group included divorced cases, single (never married) cases, widowed cases and cases separated with spouse.

*p* values were from the statistical analysis between married and unmarried patients.

Low-grade malignant tumors were defined as carcinoids, adenoid cystic carcinomas and mucoepidermoid carcinomas.

Data generated from 2000 national census data. Lower 50% indicated the patients live in counties below median level of national statistics. Upper 50% indicated the patients live in counties above median level of national statistics.

SEER 1990--2010 (*n* = 600)[^a^](#tfn_001){ref-type="table-fn"}.

Marital status and overall survival (OS) {#s2_2}
----------------------------------------

The OS curve generated using the Kaplan--Meier method shows a survival difference according to marital status (log-rank test *p* = 0.009) (Figure [1A](#F1){ref-type="fig"}). The median OS of married patients (21 months, 95% confidence interval \[CI\] 14.67--27.33 months) was longer than that of unmarried patients (13 months, 95% CI 9.70--16.30 months). Similarly, the 5-year OS rate for married patients (35.89%) was higher than that of unmarried patients (25.64%) (Table [2](#T2){ref-type="table"}). Results of the log-rank test showed that age, race, histologic type, tumor grade, disease extension, and treatment (i.e., surgery or radiotherapy) were significantly associated with OS in these patients. After adjusting for these variables and other socioeconomic factors, marital status was found to be an independent prognostic factor, and married patients had better OS compared to unmarried patients (hazard ratio \[HR\] = 0.78, 95% CI 0.64--0.95, *p* = 0.015). No significant association between county-level socioeconomic status and OS was identified by univariate or multivariate analysis (Table [2](#T2){ref-type="table"}).

![Survival curves in patients with tracheal cancer according to marital status, married vs. unmarried\
(**A**) Overall survival (OS): χ^2^ = 6.92, *p* = 0.009. (**B**) Tracheal cancer specific survival (TCSS): χ^2^ = 8.11, *p* = 0.004.](oncotarget-07-77152-g001){#F1}

###### Univariate and multivariate analysis for overall survival (OS) in tracheal cancer patients

  Variables                               5-year OS   Univariate analysis   Multivariate analysis                            
  --------------------------------------- ----------- --------------------- ----------------------- ----------- ------------ ----------
  **Sex**                                             2.82                  0.093                                            
   Female                                 33.73%                                                    Reference                
   Male                                   29.77%                                                    0.82        0.67--1.01   0.061
  **Age at diagnosis**                                107.73                \< 0.001                                         
   \< 65                                  49.21%                                                    Reference                
   ≥ 65                                   14.66%                                                    2.00        1.62--2.46   \< 0.001
  **Race**                                            8.88                  0.012                                            
   White                                  28.18%                                                    Reference                
   Black                                  37.96%                                                    0.90        0.67--1.20   0.467
   Other                                  53.92%                                                    0.90        0.60--1.34   0.600
  **Histology**                                       133.81                \< 0.001                                         
   Squamous cell carcinoma                18.45%                                                    Reference                
   Adenoid cystic carcinoma               75.12%                                                    0.82        0.38--1.75   0.601
   Small cell carcinoma                   0.00%                                                     1.22        0.86--1.73   0.264
   Others                                 36.98%                                                    0.66        0.50--0.86   0.002
  **Low-Grade Malignant Tumors**                      109.38                \< 0.001                                         
   Yes                                    72.88%                                                    Reference                
   No                                     19.74%                                                    2.27        1.15--4.47   0.018
  **Grade**                                           23.16                 \< 0.001                                         
   Grade I (well differentiated)          57.39%                                                    Reference                
   Grade II (moderately differentiated)   33.26%                                                    1.27        0.71--2.27   0.416
   Grade III (poorly differentiated)      16.74%                                                    1.73        0.97--3.11   0.065
   Grade IV (undifferentiated)            17.31%                                                    1.59        0.77--3.26   0.209
   Unknown                                37.64%                                                    1.35        0.77--2.36   0.294
  **Disease Extension**                               99.00                 \< 0.001                                         
   Localized                              45.49%                                                    Reference                
   Regional                               31.24%                                                    1.65        1.29--2.10   \< 0.001
   Distant                                11.01%                                                    2.75        2.06--3.69   \< 0.001
   Unknown                                18.29%                                                    1.50        1.10--2.04   0.009
  **Surgery**                                         167.92                \< 0.001                                         
   Surgery-total resection                61.09%                                                    Reference                
   Surgery-subtotal resection             52.26%                                                    1.80        1.06--3.05   0.029
   No cancer directed surgery             13.33%                                                    3.75        2.20--6.39   \< 0.001
   Unknown                                25.00%                                                    2.72        1.04--7.11   0.041
  **Radiotherapy**                                    7.58                  0.023                                            
   Radiotherapy                           33.39%                                                    Reference                
   No radiotherapy                        28.38%                                                    2.06        1.62--2.61   \< 0.001
   Unknown                                27.05%                                                    1.69        0.95--3.03   0.076
  **Marital Status**                                  6.92                  0.009                                            
   Unmarried                              25.64%                                                    Reference                
   Married                                35.89%                                                    0.78        0.64--0.95   0.015
  **High School Education Rate**                      0.74                  0.389                                            
   Lower 50%                              32.01%                                                    Reference                
   Upper 50%                              30.89%                                                    0.87        0.65--1.16   0.332
  **Median Household Income**                         0.66                  0.417                                            
   Lower 50%                              30.38%                                                    Reference                
   Upper 50%                              31.94%                                                    1.21        0.92--1.58   0.166
  **Unemployed**                                      1.19                  0.275                                            
   Lower 50%                              30.80%                                                    Reference                
   Upper 50%                              32.24%                                                    0.90        0.70--1.17   0.445
  **White Collar**                                    3.57                  0.059                                            
   Lower 50%                              26.40%                                                    Reference                
   Upper 50%                              33.77%                                                    0.85        0.66--1.10   0.206

SEER 1990--2010 (*n* = 600).

Marital status and tracheal cancer specific survival (TCSS) {#s2_3}
-----------------------------------------------------------

Median TCSS was also longer for married patients (98 months, 95% CI 67.45--128.56 months) than for unmarried patients (38 months, 95% CI 16.66--59.34 months, log-rank test *p* = 0.004) (Figure [1B](#F1){ref-type="fig"}). The 5-year TCSS rates for married patients and unmarried patients were 58.75% and 44.58%, respectively (Table [3](#T3){ref-type="table"}). Univariate analysis showed that age, race, histologic type, tumor grade, disease extension, and surgery type were significantly associated with TCSS. In addition, patients living in counties with higher median household incomes had better TCSS (5-year TCSS rate 55.81% vs. 42.86%, log-rank test *p* = 0.023). After adjusting for demographic, clinical, and socioeconomic factors, results of multivariate Cox regression analysis confirmed that marital status is an independent prognostic factor, with better TCSS among married patients (HR = 0.70, 95% CI 0.54--0.91, *p* = 0.008). However, multivariate analysis did not support the relationship between county-level household socioeconomic status and TCSS (HR = 0.97, 95% CI 0.69--1.36, *p* = 0.858).

###### Univariate and multivariate analysis for tracheal cancer specific survival (TCSS) in tracheal cancer patients

  Variables                               5-year TCSS   Univariate analysis   Multivariate analysis                             
  --------------------------------------- ------------- --------------------- ----------------------- ----------- ------------- ----------
  **Sex**                                               2.45                  0.118                                             
   Female                                 55.69%                                                      Reference                 
   Male                                   50.38%                                                      0.83        0.63--1.08    0.161
  **Age at diagnosis**                                  23.16                 \< 0.001                                          
   \< 65                                  61.91%                                                      Reference                 
   ≥ 65                                   41.27%                                                      1.44        1.10--1.89    0.008
  **Race**                                              7.62                  0.022                                             
   White                                  48.88%                                                      Reference                 
   Black                                  66.47%                                                      0.74        0.49--1.13    0.168
   Other                                  67.87%                                                      1.11        0.66--1.86    0.696
  **Histology**                                         88.86                 \< 0.001                                          
   Squamous cell carcinoma                40.85%                                                      Reference                 
   Adenoid cystic carcinoma               84.44%                                                      0.84        0.30--2.39    0.750
   Small cell carcinoma                   0.00%                                                       1.42        0.92--2.19    0.109
   Others                                 60.25%                                                      0.67        0.46--0.97    0.034
  **Low-Grade Malignant Tumors**                        53.23                 \< 0.001                                          
   Yes                                    83.17%                                                      Reference                 
   No                                     41.53%                                                      2.25        0.87--5.84    0.094
  **Grade**                                             13.77                 0.008                                             
   Grade I (well differentiated)          78.24%                                                      Reference                 
   Grade II (moderately differentiated)   58.88%                                                      1.12        0.52--2.43    0.773
   Grade III (poorly differentiated)      35.44%                                                      1.50        0.69--3.23    0.306
   Grade IV (undifferentiated)            32.34%                                                      1.75        0.70--4.41    0.234
   Unknown                                56.89%                                                      1.47        0.70--3.08    0.305
  **Disease Extension**                                 116.12                \< 0.001                                          
   Localized                              74.72%                                                      Reference                 
   Regional                               44.97%                                                      2.76        1.94--3.93    \< 0.001
   Distant                                21.50%                                                      4.80        3.23--7.14    \< 0.001
   Unknown                                46.50%                                                      2.20        1.41--3.43    0.001
  **Surgery**                                           94.28                 \< 0.001                                          
   Surgery-total resection                73.68%                                                      Reference                 
   Surgery-subtotal resection             71.17%                                                      1.69        0.88--3.27    0.117
   No cancer directed surgery             33.50%                                                      3.27        1.69--6.34    \< 0.001
   Unknown                                37.50%                                                      3.49        1.15--10.59   0.028
  **Radiotherapy**                                      1.45                  0.484                                             
   Radiotherapy                           53.36%                                                      Reference                 
   No radiotherapy                        52.24%                                                      1.80        1.31--2.47    \< 0.001
   Unknown                                56.79%                                                      1.08        0.47--2.49    0.854
  **Marital Status**                                    8.11                  0.004                                             
   Unmarried                              44.58%                                                      Reference                 
   Married                                58.75%                                                      0.70        0.54--0.91    0.008
  **High School Education Rate**                        0.96                  0.327                                             
   Lower 50%                              54.80%                                                      Reference                 
   Upper 50%                              50.43%                                                      1.08        0.74--1.59    0.679
  **Median Household Income**                           5.10                  0.023                                             
   Lower 50%                              42.86%                                                      Reference                 
   Upper 50%                              55.81%                                                      0.97        0.69--1.36    0.858
  **Unemployed**                                        0.03                  0.863                                             
   Lower 50%                              53.26%                                                      Reference                 
   Upper 50%                              52.19%                                                      1.25        0.88--1.76    0.210
  **White Collar**                                      2.50                  0.114                                             
   Lower 50%                              46.20%                                                      Reference                 
   Upper 50%                              55.62%                                                      1.02        0.72--1.43    0.933

SEER 1990--2010 (*n* = 600).

Subgroup analysis according to histologic type and tumor stage {#s2_4}
--------------------------------------------------------------

Prognosis of tracheal cancer varies according to histologic type, with low-grade malignant tumors (LGMTs) associated with better outcomes \[[@R16]\]. Therefore, we divided the patients into two subgroups according to histologic type: LGMT vs. non-low-grade malignant tumor (NLGMT). In the NLGMT group, the 5-year TCSS survival rate for married patients (48.48%) was higher than that of unmarried patients (31.90%, log-rank test *p* = 0.001) (Figure [2A](#F2){ref-type="fig"}, [Supplementary Table S1](#SD2){ref-type="supplementary-material"}). Results of multivariate analysis showed that marriage was an independent prognostic factor for TCSS in this subgroup (reference: unmarried patients, HR = 0.70, 95% CI 0.53--0.92, *p* = 0.012). However, in the LGMT group, marital status was not associated with TCSS (log-rank test *p* = 0.876, multivariate analysis 0.197) (Figure [2B](#F2){ref-type="fig"}, [Supplementary Table S2](#SD2){ref-type="supplementary-material"}). In contrast, no association was found between marital status and OS in either subgroup ([Supplementary Tables S3](#SD2){ref-type="supplementary-material"} and [S4](#SD2){ref-type="supplementary-material"}). Stage-by-stage univariate and multivariate analysis showed that married status was an independent prognostic factor for TCSS in localized disease (reference: unmarried patients, HR = 0.48, 95% CI 0.25--0.91, *p* = 0.023) but not in regional disease or distant metastasis ([Supplementary Tables S5](#SD1){ref-type="supplementary-material"} and [S6](#SD2){ref-type="supplementary-material"}).

![Survival curves in NLGMT and LGMT subgroup patients, married vs. unmarried\
(**A**) NLGMT subgroup, tracheal cancer specific survival (TCSS): χ^2^ = 10.60, *p* = 0.001. (**B**) LGMT subgroup, tracheal cancer specific survival (TCSS): χ^2^ = 0.02, *p* = 0.876. \* No "median survival" calculated in LGMT subgroup because event happened in less than 50% patients at the end of follow-up.](oncotarget-07-77152-g002){#F2}

DISCUSSION {#s3}
==========

In 1977, Engel challenged the traditional "biomedical model" of disease and introduced the "biopsychosocial medical model" \[[@R8]\], which still influences research, medical education, and clinical practice in the 21st century \[[@R9]\]. This model emphasizes viewing the patient as a "whole person" with emotions, feelings, and social context rather than just a disease \[[@R17]--[@R19]\].

The importance of marital status and other socioeconomic factors in cancer prognosis have since been recognized. For example, Zhang *et al*. \[[@R20]\] studied 16,910 gastric cancer patients and found that marital status was an independent prognostic factor for both OS and cancer-specific survival. In a study of 129,207 patients, LaPar *et al*. \[[@R21]\] found that socioeconomic factors such as income influenced prognosis after lung cancer surgery. However, because of the rarity of primary tracheal cancer, prognostic factors, especially socioeconomic status, are unclear. Our study found that marital status is an independent prognostic factor for survival in primary tracheal cancer, with better OS and TCSS for married patients than unmarried patients. However, because this was a retrospective study, we could not establish a causal relationship between marital status and survival. Future prospective cohort studies are needed to determine any effect of marriage on survival in patients with tracheal cancer.

Results of subgroup analysis showed that marital status was an independent prognostic factor for TCSS in patients with NLGMTs but not in those with LGMTs. It is possible that patients with LGMTs had less need for social support, given the better prognosis associated with these tumors \[[@R16], [@R22], [@R23]\]. Although some studies have found that marriage was more likely to be a protective factor in patients with advanced disease \[[@R20], [@R24], [@R25]\], our study failed to prove that marital status played a more important role in late stage patients than in early stage patients. Considering the relatively small size of each subgroup, future studies with larger sample size may be necessary to better test the relationship between marital status and survival according to tumor stage and histologic type.

Numerous studies have investigated the effect of marital status on cancer prognosis. One study evaluating survival among patients with cervical cancer reported an interaction between marital status with tumor stage and treatment \[[@R26]\]. A study on oral and laryngeal cancers suggested that married patients had earlier stage cancer at clinical presentation \[[@R27]\], possibly because a concerned spouse may encourage patients to seek medical help when symptoms are noticed. However, other studies showed no significant relationship between marital status and tumor stage at presentation \[[@R20], [@R28]\]. In our study, we found no significant difference in disease extension or treatment selection between married and unmarried patients (Table [1](#T1){ref-type="table"}). Thus, other explanations are needed to understand the relationship between marital status and prognosis in tracheal cancer.

Emotional state could be one reason. In cancer patients, clinical-level psychological distress was found to be more common in unmarried patients than in married patients, and psychological distress was negatively correlated with social support among married patients \[[@R29]\]. Cancer patients often experience high levels of anxiety and depression \[[@R14], [@R30]\], and this can affect the immune system through glucocorticoid resistance and decreased interleukin 6 level \[[@R31]\]. In addition, long-term stress can alter the type 1/type 2 cytokine balance, leading to low-grade chronic inflammation and immune cell dysfunction \[[@R32]\], which are related to tumor metastasis \[[@R33]--[@R35]\]. In addition, married status generally reflects a better financial situation, which has been reported to improve prognosis \[[@R36]\]. Furthermore, unmarried patients may have additional health care expenditures, as spouses are the major source of outpatient/informal care \[[@R37]\]. Previous studies have found that married patients are more likely to receive better quality clinical care, choose better medical centers, be more compliant with medical recommendations, receive more aggressive treatments, and recover better from surgery, all of which contribute to a better prognosis \[[@R38]--[@R40]\].

The effects of other socioeconomic factors have also been discussed in numerous studies. Although most studies suggested that personal income is related to cancer survival \[[@R41], [@R42]\], the impact of the regional economic environment (e.g., county-level median household income) remains controversial. Higher neighborhood income level has been associated with higher survival rates, which can be partially explained by differences in disease stage at presentation, first-line treatment, and comorbidities \[[@R41], [@R43], [@R44]\]. However, other studies reported no significant correlation between county-level income and survival \[[@R45]\] or an association only for patients with early stage disease \[[@R46]\]. Higher education level at the community level has also been identified as having a positive influence on survival \[[@R42], [@R47]\]; however, our analysis did not show that county-level economic status or education was significant independent prognostic factors. Finally, several studies found that race influenced prognosis for certain types of cancer (e.g., lung, liver, breast, and prostate) \[[@R48]\], whereas other studies found that the effect was minimal after adjusting for other socioeconomic factors \[[@R49]\], which is consistent with our results.

SEER provided us the opportunity to have a relatively large sample size for this rare disease. However, our study still has certain limitations. First, presently SEER does not differentiate between cohabitation (quasi-marriage) and single status; thus, patients who live with their partners may be categorized as unmarried in the SEER database. According to the United States census data, unmarried partners comprise 5.19% of all households \[[@R50]\]. These patients may have better outcomes than unmarried patients who do not live with their partners, potentially biasing our results towards the null. This factor should be taken into consideration, and more data regarding cohabitation and quasi-marriage status is needed in future studies. Second, the database did not provide information related to sexual minority status (lesbian, gay, bisexual, or transgender). Several studies have suggested that these patients may have different types of social support and prognostic factors \[[@R51]--[@R53]\]. Thus, future studies on the relationship between marital status and cancer prognosis should take sexual orientation into account. Third, the database did not provide details about the quality of the marriage (e.g., satisfaction with the relationship, sexual activity), which limits the ability to analyze the impact of marriage on prognosis in tracheal cancer. In addition, the study did not analyze changes in marital status, length of the marriage, duration of being single, lifestyle risk factors, or individual-level socioeconomic factors. As the final comment, several important clinical or treatment factors that may affect survival is also not registered in SEER, including details of surgery or treatment of chemotherapy and quality of treatment at various institutions. To verify our results, further studies with detailed data at both the county and individual levels are warranted.

In conclusion, our study based on the SEER database shows that marital status is an independent prognostic factor for survival in patients with tracheal cancer. To improve prognosis, additional social support should be considered for unmarried patients, especially those with NLGMTs. The impact of other individual-level socioeconomic factors on survival requires further study.

MATERIALS AND METHODS {#s4}
=====================

Data sources {#s4_1}
------------

All primary data were obtained by using SEER\*Stat software version 8.3.2 and the SEER database released in April 2015. County-level socioeconomic information for the year 2000 was obtained from US Census 2000 files, made available by the US Census Bureau and linked to the SEER database.

Inclusion and exclusion criteria {#s4_2}
--------------------------------

Information about patients with malignancies of the "trachea, mediastinum, and other respiratory organs" from January 1990 to December 2010 was extracted from the SEER database. Patients with histologically confirmed primary tracheal cancer (International Classification of Diseases for Oncology, Third Edition \[ICD-O-3\], code C33.9) were considered for analysis. Exclusion criteria were incomplete follow-up information, unknown survival time or survival time of 0 days, age \< 18 years, unknown race, and unknown marital status ([Supplementary Figure S1](#SD1){ref-type="supplementary-material"}).

Study variables {#s4_3}
---------------

Clinically related information extracted from the SEER database included sex, age, race, primary tumor site, histologic type, tumor grade, disease extension, surgical record, and radiotherapy. Patients were divided into two groups according to age (\< 65 years vs. ≥ 65 years). Race was classified as white, black, or other. Histologic type was further classified as squamous cell carcinoma, adenoid cystic carcinoma, small cell carcinoma, or other. Histologic type was further classified as LGMT vs. NLGMT, as previously described \[[@R16]\], with carcinoids, adenoid cystic carcinomas, and mucoepidermoid carcinomas defined as LGMTs, and all other histologic types defined as NLGMTs. Disease extension was categorized using the Collaborative Stage classification criteria, with "localized" indicating situ lesions or lesions confined to the organ of origin, "regional" indicating invasion into surrounding organs/adjacent tissues or regional lymph node metastasis, and "distant" indicating distant metastasis. The surgical record was categorized as complete, partial, none, or unknown, and procedures were listed as "radical surgery" or "total surgical removal of primary site"; "local tumor destruction" or "local tumor excision"; "simple/partial surgical removal of primary site" or "debulking"; "none"; or "unknown" in the SEER database.

Marital status was categorized as married or unmarried (including never married single, divorced, separated, and widowed). Socioeconomic factors included the following county attributes: high school education rate, median household income, unemployment rate, and proportion of white-collar workers in the population. All county attributes variables were divided into two groups by the median number.

Outcomes {#s4_4}
--------

The primary outcomes were OS and TCSS. OS was defined as the time from diagnosis to date of death from any cause. Patients who were alive on the date of last contact or at the follow-up cut-off date were censored. TCSS was defined as the time from diagnosis to date of death due to tracheal cancer. Death caused by tracheal cancer was considered an event. Patients who died from other causes or were still alive at the end of the study were censored. The follow-up cut-off date was December 31, 2012, according to the SEER database instructions.

Statistical analyses {#s4_5}
--------------------

Demographic, clinical, and socioeconomic characteristics were reported as means and standard deviations for continuous variables and percentages for categorical variables. Differences in baseline characteristics were compared by Pearson chi-squared test for categorical variables and *t*-test for continuous variables. OS and TCSS were calculated by the Kaplan--Meier method and log-rank tests were conducted to compare differences between subgroups of each variable. Multivariate Cox proportional hazard models were used to determine risk factors that affect survivorship. All *P* values were two-sided, and a value less than 0.05 were considered significant. All data were analyzed by SPSS version 20 (Statistics Package for Social Science, Chicago, IL).
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